AbbVie takes on Walgreen in fight to limit generic biotech drugs - Crain's Chicago Business (blog)

16-10-2013 Crain's Chicago BusinessComments (0)


The brand-name companies are pushing bills in state legislatures across the country that would regulate generic biotech drugs on stricter terms than the drugstores and generics makers would like. AbbVie's side lost a round this week, when California Gov.

Read more on Crain's Chicago Business

Your Comments

Login to add a comment

There are no comments yet. Be the first and leave a response!

Back to top